Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/281.1
Name: Drug, bio-affecting and body treating compositions > Nonspecific immunoeffector, per se (e.g., adjuvant, nonspecific immunosti- mulator, nonspecific immunopotentiator, nonspecific immunosuppressor, non- specific immunomodulator, etc.); or nonspecific immunoeffector, stabilizer, emulsifier, preservative, carrier, or other additive for a composition con- taining an immunoglobulin, an antiserum, an antibody, or fragment thereof, an antigen, an epitope, or other immunospecific immunoeffector > Virus (e.g., interferon-inducing virus, etc.)
Description: Subject matter involving a virus.










Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
8617566 Composition comprising VLP and amyloid beta peptide Dec. 31, 2013
8460676 Composition comprising VLP and amyloid beta peptide Jun. 11, 2013
8354114 Multi plasmid system for the production of influenza virus Jan. 15, 2013
8313897 Method for preserving viral particles Nov. 20, 2012
8268331 Nucleic acid molecules and polypeptides for immune modulation Sep. 18, 2012
8263092 Alphavirus replicon particles as immunological adjuvants Sep. 11, 2012
8057806 Viruses comprising mutant ion channel protein Nov. 15, 2011
7968101 Recombinant influenza vectors with tandem transcription units Jun. 28, 2011
7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Jun. 21, 2011
7964395 Modified vaccinia ankara virus variant and cultivation method Jun. 21, 2011
7964398 Modified vaccinia ankara virus variant and cultivation method Jun. 21, 2011
7959929 Materials and methods for respiratory disease control in canines Jun. 14, 2011
7959930 Rescue of influenza virus Jun. 14, 2011
7939086 Modified Vaccinia Ankara virus variant May. 10, 2011
7939085 Monoparamunity inducers based on attenuated rabbit myxomaviruses May. 10, 2011
7923017 Modified Vaccinia Ankara virus variant Apr. 12, 2011
7897156 Modified vaccinia virus ankara for the vaccination of neonates Mar. 1, 2011
7897159 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer Mar. 1, 2011
7862829 Viral adjuvants Jan. 4, 2011
7731974 Mutant vesicular stomatitis viruses and uses thereof Jun. 8, 2010
7622121 Heat shock proteins from Mycobacterium leprae and uses thereof Nov. 24, 2009
7459270 Modified Vaccinia Ankara virus variant Dec. 2, 2008
7335364 Modified Vaccinia Ankara virus variant Feb. 26, 2008
7320793 Molecular antigen array Jan. 22, 2008
7264810 Molecular antigen array Sep. 4, 2007
7157089 Immune responses using compositions containing stress proteins Jan. 2, 2007
7122192 Porcine circoviruses, vaccines and diagnostic reagents Oct. 17, 2006
7118755 Herpes viruses for immune modulation Oct. 10, 2006
7090853 Noscapine derivatives as adjuvant compositions and methods of use thereof Aug. 15, 2006
7056689 Methods of treating and detecting cancer using viruses Jun. 6, 2006
7030094 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 Apr. 18, 2006
6964769 Molecular antigen array Nov. 15, 2005
6913752 Modified Vaccinia Ankara virus variant Jul. 5, 2005
6844000 Use of Parapox B2L protein to treat cancer and modify immune responses Jan. 18, 2005
6805870 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament Oct. 19, 2004
6756044 Antigenic complexes and methods Jun. 29, 2004
6685950 Methods of treating viral infections Feb. 3, 2004
6682743 Altered strain of the modified vaccinia virus ankara (MVA) Jan. 27, 2004
6667295 DNA vaccine against feline immunodeficiency virus Dec. 23, 2003
6660272 Porcine circoviruses, vaccines and diagnostic reagents Dec. 9, 2003
6632647 Use of strains of parapoxvirus ovis against organ fibrosis Oct. 14, 2003
6534067 Rotavirus enterotoxin adjuvant Mar. 18, 2003
6506385 Live vaccines and methods of treatment therewith Jan. 14, 2003
6379679 Multiple branch peptide construction Apr. 30, 2002
6372221 Immunogenic constructs comprising flaviviruses or flavivirus derivatives Apr. 16, 2002
6190666 DNA expression systems based on alphaviruses Feb. 20, 2001
6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses Dec. 19, 2000
6048530 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens Apr. 11, 2000
6045802 Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Apr. 4, 2000
5879685 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them Mar. 9, 1999

1 2










 
 
  Recently Added Patents
Switchable solvents and methods of use thereof
Method of transmitting and receiving wireless resource information
Packaging
Push mechanism for efficiently sending aggregated data items to client
Once daily formulations of tetracyclines
Method of optimizing air mover performance characteristics to minimize temperature variations in a computing system enclosure
Apparatus with a local timing circuit that generates a multi-phase timing signal for a digital signal processing circuit
  Randomly Featured Patents
UV curable paint compositions and method of making and applying same
Liquid crystal display
DNA encoding hK2 variant polypeptides
Image coding method and an image coding apparatus
Sunscreen agents, sunscreen compositions and method for preventing sunburn
Candle-powered aroma generator
Bolt-type seal lock
Frame padding for wireless communications
Bis-aromatic a,.beta.-unsaturated ketones
Supplementary force heat-recoverable connecting device